 Kalpana Velmurugan
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 145 | 0.430 |
Why?
| | Carcinogenesis | 4 | 2018 | 229 | 0.410 |
Why?
| | Neural Stem Cells | 2 | 2012 | 166 | 0.400 |
Why?
| | Venoms | 1 | 2012 | 22 | 0.360 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 3 | 2017 | 29 | 0.360 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2011 | 95 | 0.350 |
Why?
| | Neuroprotective Agents | 1 | 2012 | 143 | 0.340 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2012 | 146 | 0.340 |
Why?
| | Enzyme Induction | 1 | 2008 | 88 | 0.290 |
Why?
| | Antioxidants | 2 | 2011 | 549 | 0.290 |
Why?
| | Heme Oxygenase-1 | 1 | 2008 | 74 | 0.280 |
Why?
| | Stem Cells | 1 | 2012 | 626 | 0.270 |
Why?
| | Cell Differentiation | 2 | 2012 | 2050 | 0.260 |
Why?
| | Signal Transduction | 7 | 2019 | 5226 | 0.250 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.230 |
Why?
| | Hypoxia | 1 | 2012 | 1199 | 0.210 |
Why?
| | Anthracenes | 3 | 2019 | 31 | 0.210 |
Why?
| | Apoptosis | 2 | 2012 | 2430 | 0.210 |
Why?
| | Cytokines | 1 | 2012 | 2061 | 0.200 |
Why?
| | Fluorenes | 2 | 2019 | 46 | 0.180 |
Why?
| | Cell Line | 5 | 2019 | 2882 | 0.180 |
Why?
| | Lung | 6 | 2018 | 4109 | 0.170 |
Why?
| | Printing | 1 | 2019 | 5 | 0.150 |
Why?
| | Paper | 1 | 2019 | 9 | 0.150 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2637 | 0.150 |
Why?
| | Eicosanoids | 1 | 2019 | 58 | 0.140 |
Why?
| | Mucin 5AC | 1 | 2018 | 70 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 120 | 0.140 |
Why?
| | Glutathione | 2 | 2011 | 375 | 0.140 |
Why?
| | Mitogens | 1 | 2017 | 55 | 0.130 |
Why?
| | Air Pollution, Indoor | 1 | 2019 | 181 | 0.130 |
Why?
| | Carcinogens | 1 | 2017 | 122 | 0.130 |
Why?
| | Environmental Monitoring | 1 | 2019 | 377 | 0.120 |
Why?
| | Particulate Matter | 1 | 2019 | 347 | 0.120 |
Why?
| | Epiregulin | 1 | 2016 | 2 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2012 | 4154 | 0.120 |
Why?
| | Promoter Regions, Genetic | 2 | 2012 | 1257 | 0.120 |
Why?
| | Insulin-Secreting Cells | 2 | 2012 | 388 | 0.120 |
Why?
| | Inflammation | 3 | 2017 | 2878 | 0.110 |
Why?
| | Pulmonary Alveoli | 1 | 2017 | 383 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 233 | 0.110 |
Why?
| | Air Pollutants | 1 | 2019 | 438 | 0.110 |
Why?
| | Mice, Inbred BALB C | 4 | 2019 | 1253 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 276 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 266 | 0.100 |
Why?
| | Mice | 8 | 2018 | 18339 | 0.100 |
Why?
| | Response Elements | 2 | 2011 | 89 | 0.090 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2012 | 55 | 0.090 |
Why?
| | Connexin 43 | 3 | 2017 | 36 | 0.090 |
Why?
| | Adenocarcinoma | 2 | 2016 | 928 | 0.090 |
Why?
| | Chalcone | 1 | 2011 | 2 | 0.090 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2012 | 148 | 0.090 |
Why?
| | Gap Junctions | 3 | 2017 | 67 | 0.090 |
Why?
| | Animals | 10 | 2019 | 38058 | 0.080 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 153 | 0.080 |
Why?
| | Enzyme Activation | 3 | 2019 | 766 | 0.080 |
Why?
| | Neural Pathways | 1 | 2012 | 311 | 0.080 |
Why?
| | Mice, Nude | 1 | 2012 | 682 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2016 | 846 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1455 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2027 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1180 | 0.070 |
Why?
| | Pancreas | 1 | 2012 | 341 | 0.070 |
Why?
| | Reperfusion Injury | 1 | 2012 | 300 | 0.070 |
Why?
| | Drugs, Chinese Herbal | 1 | 2008 | 24 | 0.070 |
Why?
| | Protein Kinase C-delta | 1 | 2008 | 46 | 0.070 |
Why?
| | Curcumin | 1 | 2008 | 25 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 121 | 0.070 |
Why?
| | Drug Synergism | 1 | 2008 | 357 | 0.070 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 165 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2608 | 0.070 |
Why?
| | Herpesvirus 3, Human | 1 | 2011 | 336 | 0.070 |
Why?
| | Computer Simulation | 1 | 2012 | 1025 | 0.060 |
Why?
| | Pharmaceutical Preparations | 1 | 2008 | 170 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 380 | 0.060 |
Why?
| | Molecular Weight | 2 | 2019 | 327 | 0.060 |
Why?
| | Butylated Hydroxytoluene | 2 | 2016 | 36 | 0.060 |
Why?
| | Islets of Langerhans | 1 | 2012 | 833 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2008 | 618 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2017 | 292 | 0.050 |
Why?
| | Cell Communication | 2 | 2017 | 324 | 0.050 |
Why?
| | Phosphorylation | 2 | 2019 | 1732 | 0.040 |
Why?
| | Neurons | 1 | 2011 | 1640 | 0.040 |
Why?
| | Humans | 9 | 2019 | 144759 | 0.040 |
Why?
| | Epithelial Cells | 2 | 2017 | 1125 | 0.040 |
Why?
| | Graphite | 1 | 2019 | 14 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.040 |
Why?
| | Metals | 1 | 2019 | 142 | 0.030 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2017 | 5 | 0.030 |
Why?
| | DNA Adducts | 1 | 2017 | 16 | 0.030 |
Why?
| | Benzo(a)pyrene | 1 | 2017 | 8 | 0.030 |
Why?
| | Particle Size | 1 | 2019 | 411 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 173 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 253 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 89 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 851 | 0.030 |
Why?
| | Mutation | 2 | 2018 | 4089 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 7173 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 218 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2018 | 627 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1382 | 0.030 |
Why?
| | Male | 4 | 2018 | 72315 | 0.030 |
Why?
| | Gene Deletion | 1 | 2016 | 389 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3540 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 727 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2182 | 0.020 |
Why?
| | Cell Death | 1 | 2013 | 383 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 16 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1313 | 0.020 |
Why?
| | Virology | 1 | 2011 | 36 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2011 | 79 | 0.020 |
Why?
| | Metalloporphyrins | 1 | 2011 | 66 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1490 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 1045 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 370 | 0.020 |
Why?
| | Pneumonia | 1 | 2016 | 631 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4282 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2011 | 383 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 222 | 0.020 |
Why?
| | Viral Proteins | 1 | 2011 | 355 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 621 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1511 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 969 | 0.020 |
Why?
| | Fibroblasts | 1 | 2011 | 1034 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2011 | 1339 | 0.010 |
Why?
| | Female | 1 | 2018 | 78271 | 0.000 |
Why?
|
|
Velmurugan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|